Denis Glotz

1993–2025 年に発表

71
論文数
18,866
被引用数
61
h 指数
70
i10 指数

被引用数

Denis Glotz の年別被引用数1983 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 6 件1997 年: 被引用 4 件1998 年: 被引用 7 件1999 年: 被引用 10 件2000 年: 被引用 4 件2001 年: 被引用 9 件2002 年: 被引用 7 件2003 年: 被引用 39 件2004 年: 被引用 36 件2005 年: 被引用 33 件2006 年: 被引用 40 件2007 年: 被引用 53 件2008 年: 被引用 61 件2009 年: 被引用 78 件2010 年: 被引用 108 件2011 年: 被引用 111 件2012 年: 被引用 123 件2013 年: 被引用 122 件2014 年: 被引用 144 件2015 年: 被引用 185 件2016 年: 被引用 168 件2017 年: 被引用 177 件2018 年: 被引用 141 件2019 年: 被引用 618 件2020 年: 被引用 558 件2021 年: 被引用 573 件2022 年: 被引用 402 件2023 年: 被引用 286 件2024 年: 被引用 394 件2025 年: 被引用 157 件2026 年: 被引用 9 件1984〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,273 件、この内訳の 25.5%フランス: 引用元論文 459 件、この内訳の 9.2%ドイツ: 引用元論文 354 件、この内訳の 7.1%イギリス: 引用元論文 313 件、この内訳の 6.2%カナダ: 引用元論文 309 件、この内訳の 6.2%オランダ: 引用元論文 224 件、この内訳の 4.5%スペイン: 引用元論文 194 件、この内訳の 3.9%イタリア: 引用元論文 191 件、この内訳の 3.8%中国: 引用元論文 189 件、この内訳の 3.8%ベルギー: 引用元論文 176 件、この内訳の 3.5%スイス: 引用元論文 161 件、この内訳の 3.2%オーストリア: 引用元論文 145 件、この内訳の 2.9%
0%25.5%その他 20.2%

分野

  • Medicine85.8%
  • Immunology and Microbiology7.4%
  • Biochemistry, Genetics and Molecular Biology4.4%
  • Computer Science1%
  • Agricultural and Biological Sciences0.5%
  • Engineering0.3%
  • その他0.6%

トピック

  • Renal Transplantation Outcomes and Treatments21%
  • Organ Transplantation Techniques and Outcomes7.6%
  • Transplantation: Methods and Outcomes6.2%
  • Renal Diseases and Glomerulopathies5.2%
  • Organ Donation and Transplantation4.2%
  • Complement system in diseases3.1%
  • その他52.7%

共著者

全論文

検索で開く
  1. The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marion Rabant, Lorraine C. Racusen, Parmjeet Randhawa, Blaise Robin, Ivy A. Rosales, Ruth Sapir‐Pichhadze, Carrie A. Schinstock, Daniel Serón, Harsharan K. Singh, R. Neal Smith, Mark D. Stegall, Adriana Zeevi, Kim Solez, Robert B. Colvin, Michael Mengel - American Journal of Transplantation 2020 被引用: 808

  2. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Transplantation 2017 被引用: 1,030

  3. Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - BMJ 2019 被引用: 343

  4. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline G. O’Leary, Scott M. Palmer, Parmjeet Randhawa, John D. Smith, Laurie D. Snyder, Randall C. Starling, Stuart C. Sweet, Timuçin Taner, Craig J. Taylor, E. Steve Woodle, Adriana Zeevi, Peter Nickerson - American Journal of Transplantation 2018 被引用: 292

  5. Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Transplantation 2014 被引用: 1,347

  6. Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 833

  7. Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Transplantation 2012 被引用: 776

  8. Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial

    著者: , , , , , , , , , , - American Journal of Transplantation 2019 被引用: 146

  9. Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data

    著者: , , , , , , , , , , , , , , , , , , , , , , , - BMJ 2014 被引用: 326

  10. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts

    著者: , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2015 被引用: 293

  11. Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation

    著者: , , , , , , , , , - Journal of the American Society of Nephrology 2010 被引用: 775

  12. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Surya V. Seshan, B. Sis, Harsharan K. Singh, Carrie A. Schinstock, Anat R. Tambur, Adriana Zeevi, Michael Mengel - American Journal of Transplantation 2016 被引用: 624

  13. Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. Neal Smith, Marialuisa Valente - American Journal of Transplantation 2008 被引用: 1,856

  14. Disparities in Acceptance of Deceased Donor Kidneys Between the United States and France and Estimated Effects of Increased US Acceptance

    著者: , , , , , , , , , , , , - JAMA Internal Medicine 2019 被引用: 184

  15. Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients

    著者: , , , , , , , , , , - Journal of the American Society of Nephrology 2017 被引用: 249

  16. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2017 被引用: 115

  17. Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information

    著者: , , , , , , , - American Journal of Transplantation 2015 被引用: 259

  18. Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2018 被引用: 104

  19. Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell–mediated rejection

    著者: , , , , , , , , , , , - American Journal of Transplantation 2019 被引用: 94

  20. Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies

    著者: , , , , , , , , , , , , , , , , - American Journal of Transplantation 2019 被引用: 91

  21. Antibody-mediated vascular rejection of kidney allografts: a population-based study

    著者: , , , , , , , , , , , , , , , , - The Lancet 2012 被引用: 332

  22. IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury

    著者: , , , , , , , , , , , - Journal of the American Society of Nephrology 2015 被引用: 283

  23. Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - BMJ 2015 被引用: 190

  24. Molecular Microscope Strategy to Improve Risk Stratification in Early Antibody-Mediated Kidney Allograft Rejection

    著者: , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2014 被引用: 144